Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
Sonu Bhaskar(New South Wales Department of Health), Shelby Kutty(BayCare Health System), Akansha Sinha(UNSW Sydney), Robert Weissert(Hertie Institute for Clinical Brain Research), Maciej Banach(John Paul II Catholic University of Lublin), Anupama Ramakanth Pai(National Institute of Mental Health and Neurosciences), Shikha Mittoo(University Health Network), Joseph S. Kass(Baylor College of Medicine), Santhosh Rajagopal(World Health Organization - India)
Cited by 519
Related Papers
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet Neurology|2021|7.9k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet. Gastroenterology & hepatology|2020|1.7k
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|674
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644